Literatur
- 1
Bergkvist L, Frisell J, Liljegren G, Celebioglu F, Damm S, Thörn M.
Multicentre study of detection and false-negative rates in sentinel node biopsy
for breast cancer.
Br J Surg.
2001;
88
1644-1648
- 2
Cserni G. for the European Working Group for Breast Screening Pathology .
Pathologic work-up of sentinel lymph nodes in breast cancer: Review of current
data to be considered for the formulation of guidelines.
Eur J Cancer.
2003;
39
1654-1667
- 3
Giuliano A E, Jones R C, Brennan M. et al .
Sentinel Lymphadenectomy in breast cancer.
J Clin Oncol.
1997;
15
2345-2350
- 4
Giuliano A E, Haigh P I, Brennan M B, Hansen N M. et al .
Prospective observational study of sentinel lymphadenectomy without further
axillary dissection in patients with sentinel-node-negative breast cancer.
J Clin Oncol.
2000;
18
2553-2559
- 5
Goldhirsch A, Wood W C, Gelber R D, Coates A S, Thurlimann B, Senn H J.
Meeting highlights: updated international expert consensus on the primary therapy
of early breast cancer.
J Clin Oncol.
2003;
21
3357-3365
- 6
Heuser T, Rink T, Weller E, Fitz H, Zippel H H, Kreienberg R, Kuehn T.
Impact of axillary nodal status on sentinel node mapping in breast cancer and
ist relevance for tehnical proceeding.
Breast Cancer Res Treat.
2001;
67
125-132
- 7
Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg S, Shriver C, Felman S.
The sentinel node in breast cancer: A multicenter validation study.
New Engl J Med.
1998;
339
941-946
- 8
Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I,
Kreienberg R.
Long-term-morbidity following axillary dissection in breast cancer patients
- clinical assessment, significance for life quality and the impact of demographic,
oncologic and therapeutic factors.
Breast Cancer Res Treat.
2000;
64
275-286
- 9
Kühn T, Bembenek A, Büchels H, Decker T, Dunst J, Müllerleile U, Munz D L, Ostertag H,
Sautter-Bihl M L, Schirrmeister H, Tulusan A H, Untch M, Winzer K J, Wittekind C.
Sentinel-Node-Biopsie beim Mammakarzinom. Interdisziplinär abgestimmter Konsensus
der deutschen Gesellschaft für Senologie für eine qualitätsgesicherte Anwendung
in der klinischen Routine.
Onkologe.
2003;
9
1011-1016
- 10
Kuehn T, Vogl F D, Helms G, Pueckler S, Schirrmeister H, Strueber R, Koretz K, Kreienberg R.
Sentinel Node-Biopsy is a reliable method for axillary staging in breast cancer:
results from a large prospective German multi-institutional trial.
Eur J surg Oncol.
2004;
in press
- 11
McMasters K M, Tuttle T M, Carlson D J, Brown C M. et al .
Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine
axillary dissection in multiinstitutional practice when optimal technique is
used.
J Clin Oncol.
2000;
18
2560-2566
- 12
Roumen R, Kuijt G P, Liem I H, van Beek M WP.
Treatment of 100 patients with sentinel-negative breast cancer without further
axillary dissection.
Br J Surg.
2001;
88
1639-1643
- 13
Sanidas E E, de Bree E, Tsiftis D D.
How many cases are enough for accreditation in sentinel lymph node biopsy in
breast cancer.
Am J Surg.
2003;
185
203-210
- 14
Schrenk P, Hatzi-Griesenhofer M, Shamiyeh A, Waynad W.
Follow-up of sentinel node negative breast cancer patients without axillary
lymph node dissection.
J Surg Oncol.
2001;
77
165-170
- 15
Schwartz G F, Giuliano A E, Veronesi U. (for the Consensus Conference Comittee) .
Proceedings of the consensus conference on the role of sentinel lymph node biopsy
in carcinoma of the breast, April 19 - 22, 2001, Piladelphia, Pennsylvania.
Cancer.
2002;
94
2542-2551
- 16
Siegel B M, Mayzel K M, Love S M.
Level I and II axillary dissection in the treatment of early stage breast cancer:
an analysis of 259 consecutive patients.
Arch Surg.
1990;
125
114-117
- 17
Tafra L, Lannin D R, Swanson M S, Van Eyk J J, Verbanac K M, Chua A N, Ng P C, Edwards M S,
Halliday B E, Henry C A, Sommers L M, Carman C M, Molin M R, Yurko J E, Perry R R,
Williams R.
Multicenter trial of sentinel node biopsy for breast cancer using both technetium
sulfur colloid and isosulfan blue dye.
Ann Surg.
2001;
233
51-59
- 18
Veronesi U, Paganelli G, Viale G, Path F R, Luini A, Zurrido S, Galimberti V, Intra M,
Veronesi P, Robertson G, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R.
A randomized comparison of sentinel-node biopsy with routine axillary dissection
in breast cancer.
N Engl J Med.
2003;
349
546-553
Priv.-Doz. Dr. med. Th. Kühn
Frauenklinik Gifhorn
Bergstraße 30
38518 Gifhorn
Telefon: 05371/871601
Fax: 05371/871608
eMail: kuehn.thorsten@t-online.de
